MedTrace Logo

Probiotics for Chalaziosis Treatment in Children

NCT04322500 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2020-05-05

Study results available
· View outcomes & findings →

Summary

There is growing evidence encouraging the use of probiotics in many conditions in children. The aim of the investigator's study is to define the possible beneficial impact of probiotics on paediatric patients affected by chalaziosis.

Conditions

  • Chalazion

Interventions

DIETARY_SUPPLEMENT

probiotics

use specific probiotics in addiction to conservative treatment to modify the intestinal microbiome to ameliorate the clinical course of chalaziosis in children by re-establishing intestinal and immune homeostasis

OTHER

conservative treatment

lid hygiene, warm compression, and dexamethasone/tobramycin ointment for at least 20 days

Sponsors & Collaborators

  • University of Molise

    lead OTHER

Principal Investigators

  • Ciro Costagliola, Full Professor · University of Molise

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2020-02-29
Completion
2020-02-29

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04322500 on ClinicalTrials.gov